Is Encapsulated Medullary Thyroid Carcinoma Associated With a Better Prognosis? A Case Series and a Review of the Literature
ContextMedullary thyroid carcinoma (MTC) is a malignant neuroendocrine neoplasm that may spread to lymph nodes before the primary tumor is diagnosed; moreover, distant metastases are already present in about 10% of patients at diagnosis. Serum calcitonin (Ctn) usually reflects the spread of disease,...
Main Authors: | Andrea Contarino, Alessia Dolci, Marco Maggioni, Francesca Maria Porta, Gianluca Lopez, Uberta Verga, Francesca Marta Elli, Elisabetta Francesca Iofrida, Gianmaria Cantoni, Giovanna Mantovani, Maura Arosio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.866572/full |
Similar Items
-
Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
by: Wenliang Yue, et al.
Published: (2022-11-01) -
To screen or not to screen for medullary thyroid cancer? This is (yet) the question. An illustrative case.
by: Rosaria Ruggeri, et al.
Published: (2018-12-01) -
Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center
by: Sun Jung Kim, et al.
Published: (2021-11-01) -
Progress of study on medullary thyroid carcinoma with serum calcitonin-negative and large mass
by: LI Rui, LIU Zhuoran, YAN Jiqi
Published: (2022-06-01) -
False positive results using calcitonin as a screening method for medullary thyroid carcinoma
by: Rafael Loch Batista, et al.
Published: (2013-01-01)